Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?

PURPOSE OF REVIEW: Adoption of poor lifestyles (inactivity and energy-dense diets) has driven the worldwide increase in the metabolic syndrome, type 2 diabetes mellitus and non-alcoholic steatohepatitis (NASH). Of the defining features of the metabolic syndrome, an atherogenic dyslipidaemia characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Fruchart, Jean-Charles, Hermans, Michel P., Fruchart-Najib, Jamila, Kodama, Tatsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Statin Drugs (R. Ceska, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779417/
https://www.ncbi.nlm.nih.gov/pubmed/33392801
http://dx.doi.org/10.1007/s11883-020-00897-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779417/
https://www.ncbi.nlm.nih.gov/pubmed/33392801
http://dx.doi.org/10.1007/s11883-020-00897-x

Ejemplares similares